Gov. Inslee warns of 4th pandemic wave as vaccine availability opens wide

Starting Thursday, more COVID-19 vaccinations are available to more people than ever before in Washington. But Governor Inslee says the threat has not completely waned, warning a fourth wave is a concerning possibility.

Lack of vaccines in other parts of world puts US at risk, could prolong pandemic, experts say

Dr. Anthony Fauci, the nation’s leading expert on infectious diseases, said the longer the novel coronavirus is allowed to replicate in any part of the world, the more opportunity new variants have to emerge and threaten the country’s chance of reaching herd immunity.

US opens more distance in worldwide race against COVID-19 as it nears 200M vaccines administered

Nearly half of American adults have gotten at least one dose of the vaccine, and about 30% have been fully vaccinated. But the picture is still relentlessly grim in parts of Europe, Latin America, Africa and Asia.

Meet the 'Vaccine Fairy'
video

Nancy Baker joins Q13 News This Morning to share her secrets on finding vaccine appointments for strangers.

Vaccine fairy works magic for hundreds across Western Washington

A Snoqualmie Ridge mom's persistence, patience and philanthropy have garnered her the nickname of the vaccine fairy.

Bothell man receives third dose of Moderna vaccine as part of booster trial

It has been a full year since the first group of local Moderna vaccine trial participants rolled up their sleeves for the COVID-19 vaccine in Seattle.

Vaccine 'breakthrough' cases double in Washington, but still .01 percent of all vaccinations

The number of people infected with COVID-19 after being fully vaccinated has more than doubled in Washington, but health officials stress that breakthrough cases are expected with any vaccine.

The Vaccine Fairy of Western Washington
video

A Snoqualmie Ridge mom saw a need and quickly stepped up to help in a big way.

Blood clot symptoms to look out for if you received the Johnson & Johnson vaccine

The Washington State Department of Health said Johnson & Johnson blood clot risk is less than one in a million, but paused injections Tuesday out of an abundance of caution.

Russ and Ciara to host vaccination special featuring President Biden and former President Barack Obama

Seahawks quarterback Russell Wilson and wife Ciara will host a Sunday night TV special featuring President Biden, Dr. Anthony Fauci and a slew of celebrities hoping to educate Americans and dispel vaccine concerns. 

Washington state follows feds in halting use of J&J vaccine

Washington is immediately halting the use of the one-dose Johnson & Johnson vaccine against the coronavirus, following the guidance of the federal government regarding the appearance of rare side effects in a handful of women across the country.

Online COVID-19 vaccine locators prepare for influx in users once eligibility opens to all adults April 15

More than 3.7 million doses of the coronavirus vaccine have gone into the arms of people across Washington state. As the state prepares to open up vaccines to all adults on April 15, getting a spot in line will be a bit tougher.

CDC says Johnson & Johnson shots can continue in North Carolina after reports of adverse reactions

Federal health officials say it’s safe to continue administering Johnson & Johnson shots at three vaccination sites in North Carolina that had an increase in reports of adverse reactions on Thursday.

Nearly 80% of teachers, child care workers have received at least 1 dose of COVID-19 vaccine

White House officials announced that nearly 80 percent of teachers, school staff members and child care workers have received at least a single dose of the COVID-19 vaccine.

Biden moves COVID-19 vaccine eligibility date for all US adults up to April 19

President Joe Biden on Tuesday plans to announce that every U.S. adult will be eligible for a COVID-19 vaccine by April 19, the Associated Press reports.

Moderna COVID-19 vaccine protection lasts at least 6 months, study finds

New research suggests Moderna’s vaccine against COVID-19 offers protection for at least six months, echoing findings from Pfizer last week.